Furthermore, by upregulating PPAR expression and suppressing inflammatory cytokine levels, fibroblast growth factor 21 (FGF-21) reduces pulmonary hypertension and suppressing inflammatory cytokine levels. This evidence concerns the gene FGF21 and pulmonary hypertension.